The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive.
Journavx is approved to treat moderate-to-severe acute pain in adults, such as pain following surgery or injury. Suzetrigine, the active…
New FDA-Approved Painkiller Is a Safer Alternative to Opioids …C0NTINUE READING >>>>